Exane Derivatives Tilray Brands, Inc. Transaction History

Exane Derivatives

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$3.11 - $7.48 $9,553 - $22,978	-3,072 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$4.88 - $8.56 $14,991 - $26,296	3,072 New	3,072 $23,000
Q4 2021 Jan 28, 2022	SELL	$7.03 - $13.03 $21,596 - $40,028	-3,072 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$13.68 - $22.34 $31,163 - $50,890	2,278 Added 286.9%	3,072 $55,000
Q1 2021 Apr 30, 2021	SELL	$9.0 - $63.91 $1,539 - $10,928	-171 Reduced 17.72%	794 $18,000
Q4 2020 Jan 27, 2021	BUY	$4.82 - $10.1 $3,022 - $6,332	627 Added 185.5%	965 $7,000
Q3 2020 Oct 08, 2020	BUY	$4.7 - $8.7 $1,588 - $2,940	338 New	338 $1,000
Q3 2020 Oct 06, 2020	SELL	$4.7 - $8.7 $61,433 - $113,717	-13,071 Closed	0 $0
Q2 2020 Jul 10, 2020	BUY	$5.54 - $10.81 $10,586 - $20,657	1,911 Added 17.12%	13,071 $92,000
Q1 2020 Apr 17, 2020	SELL	$2.47 - $21.36 $6,175 - $53,400	-2,500 Reduced 18.3%	11,160 $76,000
Q4 2019 Jan 22, 2020	BUY	$15.72 - $24.88 $2,452 - $3,881	156 Added 1.16%	13,660 $233,000
Q3 2019 Oct 15, 2019	SELL	$24.74 - $49.3 $79,563 - $158,548	-3,216 Reduced 19.23%	13,504 $334,000
Q2 2019 Jul 12, 2019	BUY	$34.66 - $63.73 $535,185 - $984,054	15,441 Added 1207.27%	16,720 $0
Q1 2019 Apr 24, 2019	SELL	$64.85 - $100.15 $543,832 - $839,857	-8,386 Reduced 86.77%	1,279 $0
Q4 2018 Jan 31, 2019	BUY	$65.89 - $165.64 $603,881 - $1.52 Million	9,165 Added 1833.0%	9,665 $681,000
Q3 2018 Oct 24, 2018	BUY	$22.1 - $214.06 $11,050 - $107,030	500 New	500 $0

405

99.8M

8.6M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $874M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

Stay updated on Exane Derivatives with notifications on news.